Characterizing the Epidemiological Transition in Mexico: National and Subnational Burden of Diseases, Injuries, and Risk Factors

Abstract

Mexico is at an advanced stage in the epidemiologic transition, with the majority of the disease and injury burden from noncommunicable diseases. A unique characteristic of the epidemiological transition in Mexico is that overweight and obesity, high blood glucose, and alcohol use are responsible for larger burden of disease than other noncommunicable disease risks such as tobacco smoking. The Southern region is least advanced in the epidemiological transition and suffers from the largest burden of ill health in all disease and injury groups.

Keywords

MedicineEpidemiological transitionEpidemiologyEnvironmental healthYears of potential life lostMortality rateMalnutritionDisease burdenCause of deathDiseaseDemographyPopulationLife expectancySurgeryPathology

Affiliated Institutions

Related Publications

Evidence-Based Health Policy—Lessons from the Global Burden of Disease Study

Christopher Murray , Alan D López

The Global Burden of Disease Study, a comprehensive regional and global assessment of mortality and disability from 107 diseases and injuries and 10 risk factors, is an example ...

1996 Science 2167 citations

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Theo Vos , Stephen S Lim , Cristiana Abbafati +97 more

In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the n...

2020 The Lancet 17468 citations

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Spencer L James , Degu Abate , Kalkidan Hassen Abate +97 more

The Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years lived with disability (YL...

2018 The Lancet 13391 citations

Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Christopher J L Murray , Aleksandr Y. Aravkin , Peng Zheng +97 more

Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is ma...

2020 The Lancet 8688 citations

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

Gregory A. Roth , George A. Mensah , Catherine O. Johnson +97 more

Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are the leading cause of global mortality and a major contributor to disability. This paper ...

2020 Journal of the American College of Ca... 9673 citations

Publication Info

Year: 2008
Type: article
Volume: 5
Issue: 6
Pages: e125-e125
Citations: 251
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Characterizing the Epidemiological Transition in Mexico: National and Subnational Burden of Diseases, Injuries, and Risk Factors

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

251

OpenAlex

Cite This

APA Style

                            
                                
                                    Gretchen A Stevens, 
                                
                                    Rodrigo H Dias, 
                                
                                    Kevin J. A. Thomas
                                
                                et al.
                            
                            (2008). 
                            Characterizing the Epidemiological Transition in Mexico: National and Subnational Burden of Diseases, Injuries, and Risk Factors. 
                            PLoS Medicine
                            , 5
                            (6)
                            , e125-e125.
                            https://doi.org/10.1371/journal.pmed.0050125
                        

Identifiers

DOI: 10.1371/journal.pmed.0050125